创科(00669.HK):疫情下扩销售团队抢市占 料增长势头持续
创科实业(00669.HK)行政总裁Joseph Galli出席网上业绩发布会时表示,疫情下留意到部分竞争对手感到畏惧,并预计销售跌幅达双位数,但公司在疫情之初已采取了不同的策略,积极投资於生产、库存并提升产能,藉机捕捉市场份额,而疫情期间公司亦积极扩张销售团队,向客户推销产品,带动上半年销售大幅跑赢同业。
他又强调上半年的销售增长并非单次事件,认为势头将持续至下半年,而期内毛利率续提升至38%,反映除销售增长外产品组合亦有改善。他指出疫情对所有人都有影响,亦未知要多长时间应对,但会继续积极投资於可推动销售的范畴,并开发新产品助用户应对疫情,除工程承办商外,旗下产品亦可助用家自行改装家用健身室,或改装作在家学习等,认为在疫情的新常态下最重要是做足抗疫措施,保障员工及其家人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.